A critical advance in cancer study is occurring with the use of mini-antibodies to reactivate mutated p53. This crucial malignant protector protein is frequently inactivated in many forms of tumors, leading https://echobookmarks.com/story21927631/nanobodies-revive-tumor-suppressor-p53-new-promising-pathway-for-cancer-treatment